Skip to content
by Legal Desire
21 September 2026

Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Bush Lead Latham & Watkins LLP Partner Capital Markets San Diego
Omeed Valipour Latham & Watkins LLP Associate Capital Markets Not stated
Ariana Alemi Latham & Watkins LLP Associate Capital Markets Not stated
Chad Jennings Latham & Watkins LLP Counsel FDA matters Washington, D.C.
Trevor Thompson Latham & Watkins LLP Associate FDA matters Not stated
Betty Pang Latham & Watkins LLP Partner healthcare matters Bay Area
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity matters Bay Area
Chad Leiper Latham & Watkins LLP Associate data privacy and cybersecurity matters Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property matters San Diego
Andrew Wang Latham & Watkins LLP Associate intellectual property matters Not stated
Holly Bauer Latham & Watkins LLP Partner executive compensation and employee benefits matters San Diego
Julie Voorhes Latham & Watkins LLP Associate executive compensation and employee benefits matters Not stated
Eric Cho Latham & Watkins LLP Partner tax matters Los Angeles
Sina Setayeshpour Latham & Watkins LLP Associate tax matters Not stated

Stated terms

Stated value
USD 350m (US$350 million)
What the figure measures
Issue size
Client
Electra Therapeutics, Inc.Issuer
Counterparties
the underwriters (Underwriters)